Article info
Commentary
And there we go again: the ethics of placebo-controlled RCT in case of catastrophic illness
- Correspondence to Dr Udo Schuklenk, Department of Philosophy, Queen's University at Kingston, Kingston, Ontario, Canada K7L 3N6; udo.schuklenk{at}gmail.com
Citation
And there we go again: the ethics of placebo-controlled RCT in case of catastrophic illness
Publication history
- Received August 26, 2013
- Accepted September 29, 2013
- First published October 18, 2013.
Online issue publication
November 24, 2015
Article Versions
- Previous version (18 October 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Grants and Contracts, JIM 61-2
- HIV INCIDENCE ASSAYS WITH IMPROVED SPECIFICITY (R01): PA-12-012
- Off-trial access to experimental cancer agents for the terminally ill: balancing the needs of individuals and society
- News
- NIH Awards Nearly $4 Million in Support of Bench-to-Bedside Research
- Study protocol of RESCUE-ALS: A Phase 2, randomised, double-blind, placebo-controlled study in early symptomatic amyotrophic lateral sclerosis patients to assess bioenergetic catalysis with CNM-Au8 as a mechanism to slow disease progression
- Risk of sepsis in patients with amyotrophic lateral sclerosis: a population-based retrospective cohort study in Taiwan
- NEWS
- 2014 Rolf Luft Award Announced
- CHEMICAL APPROACHES TO TARGET VALIDATION FOR DRUG RESISTANT PATHOGENS (R01): RFA-AI-11-004